追踪策略

Outpoint Capital founder; investor and startup adviser
Jordan Grayson is an investor and founder of Outpoint Capital. His public professional profile lists a University of Pennsylvania bachelor’s degree in 1999 and earlier experience at firms including Credit Suisse First Boston, DLJ and Alson Capital. A contemporaneous SEC-hosted shareholder presentation identifies Outpoint as a long/short equity fund founded by him in 2005. His published investment approach focuses on research, business change and catalysts that could close a gap between market price and assessed value. His later work includes startup advising and an Autopilot strategy following biotechnology-fund disclosures. This history is separate from the generic promotional claim of a guaranteed investment edge.
Jordan Grayson人生的每个阶段对应一个八边形。八条轴各按书面评分标准、依据附有出处的书面证据打0至5分;没有证据的轴是空缺,不是零分。没有总分,也没有理想形状:它是一份概况,不是排名。外貌和性格不是轴,因为无法依据证据评分。
没有总分,也没有理想形状:轴越长表示该项越多,因此“不当行为”轴越长,表示有记录的不当行为越多。
最新公开持仓及其来源日期。持仓可能已变化。仅凭交易披露无法确定剩余股数或持仓成本。
暂无经核实的个人投资组合。个人持仓和未实现盈亏未知;相关基金或追踪策略单独显示。
本人公开的交易活动。发布日期与交易日期不同;评论文章并非完整成交记录。
已实现盈亏需要同一证券和数量的对应买入成本与卖出收入。交易金额区间、推算的季度变动及评论无法确定利润。缺少成本或成交数据时保持未披露。
暂无经核实的个人交易账簿。交易活动和已实现盈亏未知,并非为零。
健康、体重和宗教信息仅在本人、其医生或可靠媒体已公开时才会显示,每项都链接到其来源。
截至 2026年10月25日
这些是追踪策略的持仓和客户策略回报,并不证明此人的个人持仓或盈利。
| 证券 | 配置比例 | 未实现盈亏 |
|---|---|---|
| KODKodiak Sciences Inc Common Stock | 12.1% | 未披露 |
| ONCBeOne Medicines Ltd. American Depositary Shares | 6.2% | 未披露 |
| ROIVRoivant Sciences Ltd. Common Shares | 5.8% | 未披露 |
仅部分投资组合公开 · 另有16项持仓未公开 (75.9%)
个股盈亏需要公开持仓成本及同币种的日期明确的估值。此为未实现价格盈亏,不含股息或已实现收益。缺失数据不作推算。
截至 2026年10月23日 · 开始于2026年8月20日
The performance data presented reflects the aggregated results of actual client portfolios managed by the Registered Investment Adviser (RIA), based on the trading activity in the securities contained in the relevant portfolio over the specified period. If fewer than 10 clients are invested in the portfolio, the data represents the aggregate performance of all clients following this strategy. Performance figures are shown net of advisory fees, calculated using the applicable subscription fee and an assumed $50,000 account size. Because subscription fees are flat rather than asset-based, accounts smaller than $50,000 would experience a higher effective fee percentage and lower net performance, while larger accounts would experience a lower effective fee percentage. Actual investor outcomes can vary due to factors like brokerage support for fractional shares, account size, trade timing, fees, and taxes, and past performance should not be interpreted as a guarantee of future results or typical of all portfolios.
Jordan Grayson的生平资料由维基及编号参考来源支持。持仓和交易披露在各自部分注明来源。 阅读维基